About Valiant CN
Valiant CN is a publicly listed company based in Yantai (China) founded in 1995. Pharmaceutical intermediates and optical chemical products are manufactured. It operates in the Industrial Goods & Manufacturing and Healthcare sectors. The company has 4,730 employees. Valiant CN has completed 1 acquisition, including MP Biomedicals. Its focus areas include Chemicals and Materials, Materials Industry Associations and Healthcare Associations. Its legal entity is Maine Potato Growers, Inc.
Company details
Valiant was established in 1995 in Yantai, China, as an association dedicated to chemical manufacturing. Operations are conducted in the pharmaceutical and optical sectors, where intermediates for drug production and specialized optical chemicals are developed and supplied. The companys activities support industrial applications in these fields, with its online presence maintained at valiant-cn.com. Geographic focus remains on Yantai for production and distribution.
- Headquarters Yantai, China
- Employees 4,730
- Stage Public
- SectorsIndustrial Goods & ManufacturingHealthcare
- Email••••••••
- Phone•••• ••••
- Website valiant-cn.com
- Legal Name Valiant Co., Ltd. Class A
- Annual Revenue$527.07 M (USD)1.33as on Dec 31, 2025
- Net Profit$40.63 M (USD)15.51as on Dec 31, 2025
- EBITDA$124.76 M (USD)2.28as on Dec 31, 2025
- Employee Count4,730
- Investments & Acquisitions
IPO & Listings of Valiant CN
Valiant CN is a publicly listed company on the SZSE with ticker symbol 002643 in China, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Dec 2011
- Listed onSZSE: 2643
- Listed entityValiant Co., Ltd. Class A
- Exchange sectorProcess industries
- ISINCNE1000019T0
- Share price11.62 CNY (-3.25% on the day) · 2026-10-14
- Market capitalisation11,164,317,017.00 CNY
- Price to earnings43.7
- EPS (diluted, trailing year)0.27 CNY
- Dividend yield1.02%
- Volume (last session)11,136,246
Financials of Valiant CN
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 3.69B CNY | 284.5M CNY | 873.5M CNY |
| 2024 | 3.64B CNY | 246.3M CNY | 854.0M CNY |
| 2023 | 4.28B CNY | 763.0M CNY | 1.32B CNY |
| 2022 | 5.07B CNY | 721.3M CNY | 1.31B CNY |
| 2021 | 4.34B CNY | 626.7M CNY | 1.07B CNY |
Detailed financial statements for Valiant CN
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Valiant CN
Valiant CN has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MP Biomedicals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Reagents for diagnostics, chemical and life science research | mpbio.com | Santa Ana, United States | 1959 | Oct 2015 | $131.25M |
Complete acquisition details for Valiant CN
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Valiant CN
3 dated milestones of Valiant CN across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Valiant CN is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires MP Biomedicals.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Valiant Cn
Complete news archive for Valiant CN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valiant CN
Valiant CN was founded in 1995.
Valiant CN is headquartered in Yantai, China. It is registered at Yantai, Shandong, China.
Valiant CN has 4,730 employees.
Annual revenue of Valiant CN is $527.07M as on Dec 31, 2025.
Valiant was established in 1995 in Yantai, China, as an association dedicated to chemical manufacturing. Operations are conducted in the pharmaceutical and optical sectors, where intermediates for drug production and specialized optical chemicals are developed and supplied. The companys activities support industrial applications in these fields, with its online presence maintained at valiant-cn.com. Geographic focus remains on Yantai for production and distribution.
Yes, Valiant CN is publicly traded on SZSE under the ticker symbol 002643.
Valiant CN has made 1 acquisition, including MP Biomedicals.
Valiant CN operates through Maine Potato Growers, Inc.